Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
A. Gabizon, S. Gabizon-Peretz, Shadan Modaresahmadi, N. M. La-Beck
Researcher profile · Semantic Scholar
A. Gabizon, S. Gabizon-Peretz, Shadan Modaresahmadi, N. M. La-Beck
P. Back, Minzhi Yu, Shadan Modaresahmadi, Sahelosadat Hajimirzaei +4 more
M. Faeq, M. Al-Haideri, T. M. Mohammad, Farshad Gharebakhshi +3 more
P. Back, Shadan Modaresahmadi, J. Patel, Indhumathy Subramaniyan +8 more
M. Eltokhy, M. Curcic, Shadan Modaresahmadi, S. Gaikwad +2 more
M. Eltokhy, Bhaumik Patel, M. Curcic, Faizah Alabi +4 more
Siavash Shahbazi Nia, Shadan Modaresahmadi, Vithya Thirumoorthi, Q. Anwar +1 more
Md. Rakibul Islam, J. Patel, P. Back, Shadan Modaresahmadi +3 more
Wyatt Paulishak, L. Isenhower, Shadan Modaresahmadi, Sahelosadat Hajimirzaei +2 more
Shadan Modaresahmadi, Ashok Silwal, Martin Kolev, M. Karbowniczek +1 more
Armin Eisa Zaei, Siavash Shahbazi Nia, Shadan Modaresahmadi
Siavash Shahbazi Nia, Shadan Modaresahmadi, Armin Eisa Zaei
Shadan Modaresahmadi, S. Hiremath, T. Vithya, S. Prasad +2 more